生物徽标

生物基因

Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.

灵活的媒体发行

卫生诊所的生物资助气候工具包正式启动

生物基因如何推进净零供应链目标

Biogen庆祝20周年关怀

Biogen的Alex Cameron讨论了生物MIT生物技术的作用

在地球日及以后,生物基因驱动可持续的医学生产

首次交付热量饮食单饮食成功!

HBCU学生对Biogen体验进行权衡

视频

接触生物基因
open_in_new